Corcept Therapeutics | CORT - Vertriebs- Und Verwaltungskosten

Aktienkurs
46.06
Täglich Wechseln
0.98 2.17%
Monatlich
13.81%
Jährlich
-35.77%
Q2 Prognose
45.07




Vertriebs- Und Verwaltungskosten Veränderung Datum
Acadia Pharmaceuticals USD 146.73M 21.82M 2025-12
Alaunos Therapeutics USD 585K 84K 2025-09
ANI Pharmaceuticals USD 82.79M 6.13M 2025-12
Ardelyx USD 75.92M 7.69M 2025-12
Assertio Holdings USD 16.73M 1.66M 2024-09
Aurora Cannabis CAD 40.62M 1.17M 2025-12
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Canopy Growth CAD 28.9M 636K 2025-12
Corcept Therapeutics USD 114.74M 7.77M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Esperion Therapeutics USD 39.42M 456K 2025-12
J&J USD 6.03B 719M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Merck USD 2.85B 215M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Novartis USD 3.44B 128M 2025-12
Novartis USD 3.44B 132M 2025-12
Omeros USD 11.32M 2.48M 2024-09
Pacira USD 91.87M 70K 2025-12
Pfizer USD 4.08B 894M 2025-12
Supernus Pharmaceuticals USD 122.39M 57.29M 2025-12
TG Therapeutics USD 50.73M 12.64M 2025-12